BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 32683647)

  • 1. Modulating chitosan-PLGA nanoparticle properties to design a co-delivery platform for glioblastoma therapy intended for nose-to-brain route.
    Ferreira NN; Granja S; Boni FI; Prezotti FG; Ferreira LMB; Cury BSF; Reis RM; Baltazar F; Gremião MPD
    Drug Deliv Transl Res; 2020 Dec; 10(6):1729-1747. PubMed ID: 32683647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel strategy for glioblastoma treatment combining alpha-cyano-4-hydroxycinnamic acid with cetuximab using nanotechnology-based delivery systems.
    Ferreira NN; Granja S; Boni FI; Ferreira LMB; Reis RM; Baltazar F; Gremião MPD
    Drug Deliv Transl Res; 2020 Jun; 10(3):594-609. PubMed ID: 31981140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nose-to-brain co-delivery of drugs for glioblastoma treatment using nanostructured system.
    Ferreira NN; de Oliveira Junior E; Granja S; Boni FI; Ferreira LMB; Cury BSF; Santos LCR; Reis RM; Lima EM; Baltazar F; Gremião MPD
    Int J Pharm; 2021 Jun; 603():120714. PubMed ID: 34015380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mucoadhesive chitosan-poly (lactic-co-glycolic acid) nanoparticles for intranasal delivery of quetiapine - Development & characterization in physiologically relevant 3D tissue models.
    Gadhave DG; Quadros M; Ugale AR; Goyal M; Ayehunie S; Gupta V
    Int J Biol Macromol; 2024 May; 267(Pt 2):131491. PubMed ID: 38599435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intranasal delivery of Huperzine A to the brain using lactoferrin-conjugated N-trimethylated chitosan surface-modified PLGA nanoparticles for treatment of Alzheimer's disease.
    Meng Q; Wang A; Hua H; Jiang Y; Wang Y; Mu H; Wu Z; Sun K
    Int J Nanomedicine; 2018; 13():705-718. PubMed ID: 29440896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paclitaxel/methotrexate co-loaded PLGA nanoparticles in glioblastoma treatment: Formulation development and in vitro antitumor activity evaluation.
    Madani F; Esnaashari SS; Bergonzi MC; Webster TJ; Younes HM; Khosravani M; Adabi M
    Life Sci; 2020 Sep; 256():117943. PubMed ID: 32531377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intranasal delivery of Paclitaxel encapsulated nanoparticles for brain injury due to Glioblastoma.
    Zhang Y; Sun C; Zhang Q; Deng Y; Hu X; Chen P
    J Appl Biomater Funct Mater; 2020; 18():2280800020977170. PubMed ID: 33307944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nose-to-brain delivery of lamotrigine-loaded PLGA nanoparticles.
    Nigam K; Kaur A; Tyagi A; Nematullah M; Khan F; Gabrani R; Dang S
    Drug Deliv Transl Res; 2019 Oct; 9(5):879-890. PubMed ID: 30887226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of targeted curcumin (CUR) loaded PLGA nanoparticles for in vitro photodynamic therapy on human glioblastoma cell line.
    Jamali Z; Khoobi M; Hejazi SM; Eivazi N; Abdolahpour S; Imanparast F; Moradi-Sardareh H; Paknejad M
    Photodiagnosis Photodyn Ther; 2018 Sep; 23():190-201. PubMed ID: 29969678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chitosan-PLGA mucoadhesive nanoparticles for gemcitabine repurposing for glioblastoma therapy.
    Ramalho MJ; Serra É; Lima J; Loureiro JA; Pereira MC
    Eur J Pharm Biopharm; 2024 Jul; 200():114326. PubMed ID: 38759897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination nanochemotherapy of brain tumor using polymeric nanoparticles loaded with doxorubicin and paclitaxel: An in vitro and in vivo study.
    Malekpour MR; Hosseindoost S; Madani F; Kamali M; Khosravani M; Adabi M
    Eur J Pharm Biopharm; 2023 Dec; 193():175-186. PubMed ID: 37926270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of different molecular weight PLGA on flurbiprofen nanoparticles: formulation, characterization, cytotoxicity, and
    Öztürk AA; Yenilmez E; Şenel B; Kıyan HT; Güven UM
    Drug Dev Ind Pharm; 2020 Apr; 46(4):682-695. PubMed ID: 32281428
    [No Abstract]   [Full Text] [Related]  

  • 13. Chlorotoxin modified morusin-PLGA nanoparticles for targeted glioblastoma therapy.
    Agarwal S; Mohamed MS; Mizuki T; Maekawa T; Sakthi Kumar D
    J Mater Chem B; 2019 Oct; 7(39):5896-5919. PubMed ID: 31423502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced Caspase-Mediated Abrogation of Autophagy by Temozolomide-Loaded and Panitumumab-Conjugated Poly(lactic-
    Banstola A; Duwa R; Emami F; Jeong JH; Yook S
    Mol Pharm; 2020 Nov; 17(11):4386-4400. PubMed ID: 33079558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uniform carboxymethyl chitosan-enveloped Pluronic F68/poly(lactic-co-glycolic acid) nano-vehicles for facilitated oral delivery of gefitinib, a poorly soluble antitumor compound.
    Wang J; Wang F; Li X; Zhou Y; Wang H; Zhang Y
    Colloids Surf B Biointerfaces; 2019 May; 177():425-432. PubMed ID: 30798063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paclitaxel Delivery to the Brain for Glioblastoma Treatment.
    AbdEl-Haq M; Kumar A; Ait Mohand FE; Kravchenko-Balasha N; Rottenberg Y; Domb AJ
    Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination of Paclitaxel and R-flurbiprofen loaded PLGA nanoparticles suppresses glioblastoma growth on systemic administration.
    Caban-Toktas S; Sahin A; Lule S; Esendagli G; Vural I; Karlı Oguz K; Soylemezoglu F; Mut M; Dalkara T; Khan M; Capan Y
    Int J Pharm; 2020 Mar; 578():119076. PubMed ID: 31988035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced anti-angiogenic effects of bevacizumab in glioblastoma treatment upon intranasal administration in polymeric nanoparticles.
    Sousa F; Dhaliwal HK; Gattacceca F; Sarmento B; Amiji MM
    J Control Release; 2019 Sep; 309():37-47. PubMed ID: 31344424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved mucoadhesion and cell uptake of chitosan and chitosan oligosaccharide surface-modified polymer nanoparticles for mucosal delivery of proteins.
    Dyawanapelly S; Koli U; Dharamdasani V; Jain R; Dandekar P
    Drug Deliv Transl Res; 2016 Aug; 6(4):365-79. PubMed ID: 27106502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation of imatinib loaded surface decorated biodegradable nanocarriers against glioblastoma cell lines: Intracellular uptake and cytotoxicity studies.
    Khan AM; Ahmad FJ; Panda AK; Talegaonkar S
    Int J Pharm; 2016 Jun; 507(1-2):61-71. PubMed ID: 27154254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.